---
figid: PMC2001220__10549_2007_9697_Fig1_HTML
figlink: /pmc/articles/PMC2001220/figure/Fig1/
number: Fig. 1
caption: Cross-talk between signal transduction pathways and ER signaling in endocrine
  resistant breast cancer, with opportunities for targeted intervention. Estrogen
  (E2)-liganded ER activates E2-regulated genes in classical pathway (thick black
  arrow), but following long-term tamoxifen therapy resistance can develop with bidirectional
  cross-talk (gray arrows) between ER and growth factor receptors, with association
  of membrane bound ER with growth factor receptors, and/or IGFR or EGFR/HER2 activation
  of ER phosphorylation. Stars show various targeted therapies. AI aromatase inhibitor,
  SERD selective estrogen receptor down-regulator, MoAb monoclonal antibodies, TKI
  tyrosine kinase inhibitor, FTI farnesyltransferase inhibitor, CCI cell cycle inhibitor.
  Reprinted from [] with permission from the American Association for Cancer Research
pmcid: PMC2001220
papertitle: 'Femara® and the future: tailoring treatment and combination therapies
  with Femara.'
reftext: Matthew Ellis, et al. Breast Cancer Res Treat. 2007 Oct;105(Suppl 1):105-115.
pmc_ranked_result_index: '13285'
pathway_score: 0.9683514
filename: 10549_2007_9697_Fig1_HTML.jpg
figtitle: Cross-talk between signal transduction pathways and ER signaling in endocrine
  resistant breast cancer, with opportunities for targeted intervention
year: '2007'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2001220__10549_2007_9697_Fig1_HTML.html
  '@type': Dataset
  description: Cross-talk between signal transduction pathways and ER signaling in
    endocrine resistant breast cancer, with opportunities for targeted intervention.
    Estrogen (E2)-liganded ER activates E2-regulated genes in classical pathway (thick
    black arrow), but following long-term tamoxifen therapy resistance can develop
    with bidirectional cross-talk (gray arrows) between ER and growth factor receptors,
    with association of membrane bound ER with growth factor receptors, and/or IGFR
    or EGFR/HER2 activation of ER phosphorylation. Stars show various targeted therapies.
    AI aromatase inhibitor, SERD selective estrogen receptor down-regulator, MoAb
    monoclonal antibodies, TKI tyrosine kinase inhibitor, FTI farnesyltransferase
    inhibitor, CCI cell cycle inhibitor. Reprinted from [] with permission from the
    American Association for Cancer Research
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3CB
  - SOS1
  - PIK3CA
  - MAPK10
  - PIK3CD
  - PIK3R4
  - MAP2K1
  - PIK3R5
  - PIK3R6
  - MAPK13
  - EGFR
  - MYBBP1A
  - MAP2K2
  - RPS6KA6
  - RPS6KA4
  - PIK3CG
  - RPS6KA5
  - RPS6KA3
  - AKT1
  - AKT2
  - MAPK12
  - MAPK14
  - AKT3
  - NRAS
  - RPS6KA1
  - RPS6KA2
  - ERBB2
  - KRAS
  - MAPK1
  - IGF1R
  - HRAS
  - MAPK8
  - MAPK9
  - LRPAP1
  - SOS2
  - MAPK3
  - MAPK11
  - PIK3R3
  - Estrogen
  - Tamoxifen
  - Cancer
  - Lung cancer
  - Noonan syndrome
genes:
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: sos
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: p160
  symbol: P160
  source: hgnc_alias_symbol
  hgnc_symbol: MYBBP1A
  entrez: '10514'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: P90RSK
  symbol: P90RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA6
  entrez: '27330'
- word: P90RSK
  symbol: P90RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA4
  entrez: '8986'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: P90RSK
  symbol: P90RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA5
  entrez: '9252'
- word: P90RSK
  symbol: P90RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA3
  entrez: '6197'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: P90RSK
  symbol: P90RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA1
  entrez: '6195'
- word: P90RSK
  symbol: P90RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA2
  entrez: '6196'
- word: HER2
  symbol: HER-2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: IGFR
  symbol: IGFR
  source: hgnc_alias_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: RAP
  symbol: RAP
  source: hgnc_prev_symbol
  hgnc_symbol: LRPAP1
  entrez: '4043'
- word: sos
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
chemicals:
- word: Estrogen
  source: MESH
  identifier: D004967
- word: Tamoxifen
  source: MESH
  identifier: D013629
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
